Skip to main content
. 2012 Aug 21;107(7):1044–1050. doi: 10.1038/bjc.2012.369

Figure 3.

Figure 3

Progression-free and OS stratified for vatalanib administration in patients with high pVEGFR2/KDR+ (A and B) and high CD31+ (C and D) VD. P-values refer to Mantel–Haenszel and Gehan–Breslow–Wilcoxon methods, respectively. pts, patients.